α4β2 nACh Receptor pharmacophore models
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (8) , 1841-1844
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Agonists at the a4b2 Nicotinic Acetylcholine Receptors Relationships and Molecular ModellingCurrent Medicinal Chemistry, 2001
- An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labelled by [3H]-N-methylcarbamylcholineJournal of Computer-Aided Molecular Design, 2001
- The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of painEuropean Journal of Pharmacology, 2000
- Central nicotinic receptor ligands and pharmacophoresPharmaceutica Acta Helvetiae, 2000
- Improving the Nicotinic Pharmacophore with a Series of (Isoxazole)methylene-1-azacyclic Compounds: Synthesis, Structure−Activity Relationship, and Molecular ModelingJournal of Medicinal Chemistry, 1999
- A theoretical study of epibatidineJournal of the Chemical Society, Perkin Transactions 2, 1998
- Novel 3-Pyridyl Ethers with Subnanomolar Affinity for Central Neuronal Nicotinic Acetylcholine ReceptorsJournal of Medicinal Chemistry, 1996
- Epibatidine: a novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadoran poison frogJournal of the American Chemical Society, 1992
- The ensemble approach to distance geometry: application to the nicotinic pharmacophoreJournal of Medicinal Chemistry, 1986
- Structure and Activity of AcetylcholineNature, 1970